Brainstorm Cell Therapeutics Inc (NASDAQ:BCLI)
| 0.2003 Delayed Data As of Dec 08 |  -0.0217 / -9.77%Today’s Change | 0.13 Today|||52-Week Range 3.46 | -87.79% Year-to-Date |
Latest BCLI News | Press Releases
No recent news for Brainstorm Cell Therapeutics Inc.
Today’s Trading
| Previous close | 0.22 |
| Today’s open | 0.22 |
| Day’s range | 0.20 - 0.22 |
| Volume | 66,835 |
| Average volume (3 months) | 2,384,045 |
| Market cap | $9.8M |
Data as of 3:59pm ET, 12/08/2023
Growth & Valuation
| Earnings growth (last year) | +1.63% |
| Earnings growth (this year) | +14.39% |
| Earnings growth (next 5 years) | +1.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BCELAtreca Inc | -0.02 | -6.01% |
| NMGXNano Magic Inc | 0.00 | 0.00% |
| AEZSAeterna Zentaris Inc | -0.19 | -7.95% |
| ---- |
Data as of 3:59pm ET, 12/08/2023
Financials
| Next reporting date | March 28, 2024 |
| EPS forecast (this quarter) | -$0.14 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$24.3M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
